Marengo Therapeutics
PrivateLast Round
Series B
Nov 8, 2021
Total Funding Raised
$119M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Marengo Therapeutics operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Series B round in November 2021.
Marengo Therapeutics is a biotechnology company that develops precision immunotherapies for cancer and autoimmune diseases through its proprietary T-cell activation platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Marengo Therapeutics Comparables
Compare Marengo Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Normunity | 84% | |
| Repertoire Immune Medicines | 82% | |
| Crossbow Therapeutics | 78% |
For institutional investors. Book with your work email.
Marengo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 8, 2021 | ||||
| Series A | Jan 3, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Marengo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Apple Tree Partners | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 122% MoM, reaching 4.9K.
- Apr 17, 2026
Unveiled partnered STAR program IPN01203/STAR0501, now in Phase 1 trials.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresAug 6, 2026
Marengo Therapeutics, Inc. appoints Saso Cemerski as senior vice president, head of immunology to lead immunology research across its clinical and pre-clinical portfolio in Massachusetts on Aug 6th '26.
For institutional investors. Book with your work email.
Marengo Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Marengo Therapeutics's valuation, stock price, and market status.
Is Marengo Therapeutics a public or private company?
Marengo Therapeutics is a private company.
What is the current stock price of Marengo Therapeutics?
Marengo Therapeutics is a private company, so its shares have no public market price. Caplight tracks Marengo Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Marengo Therapeutics worth (valuation)?
Valuation information for Marengo Therapeutics is not publicly available.
Can I buy Marengo Therapeutics stock?
Marengo Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Marengo Therapeutics's last funding round?
Marengo Therapeutics's most recent funding round was Series B on November 8, 2021.
Who are the main investors in Marengo Therapeutics?
Key investors in Marengo Therapeutics include Apple Tree Partners.
Will Marengo Therapeutics IPO soon?
No public IPO plans have been announced for Marengo Therapeutics.
How can I track Marengo Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Marengo Therapeutics's shares on secondary markets.